
Estudo de Docking da Bcr-Abl (PDB, 1OPJ) com Inibidores de Segunda Geração: Dasatinibe e Afatinibe
Author(s) -
Kelvyn M. L. Rocha,
Érica C. M. Nascimento,
João B. L. Martins
Publication year - 2020
Language(s) - Portuguese
Resource type - Conference proceedings
DOI - 10.21826/viiiseedmol2020151
Subject(s) - imatinib , dasatinib , myeloid leukemia , cancer research , nilotinib , abl , afatinib , mutant , medicine , apoptosis , docking (animal) , pharmacology , chemistry , cancer , biochemistry , gene , receptor , tyrosine kinase , nursing , epidermal growth factor receptor , erlotinib